Get started
Author

Giulia Meoni

Observed name: G. Meoni
ORCID: 0000-0002-2683-1123
Observed ORCID: 0000-0002-2683-1123
OpenAlex ID: A5046064246
Medical treatment of advanced non-small cell lung cancer in elderly patients: A review of the role of chemotherapy and targeted agents
2013 · Giulia Meoni, Fabiana Letizia Cecere, et al. · Journal of Geriatric Oncology · 52
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer
2013 · Francesca Mazzoni, Fabiana Letizia Cecere, et al. · Lung Cancer · 37
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors
2017 · L. Antonuzzo, M. Del Re, et al. · Cancer Treatment Reviews · 23
PDF
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
2024 · Francesco Passiglia, Angela Listì, et al. · Journal of Thoracic Oncology · 17
Somatostatin analogs in pregnant patients with neuroendocrine tumor
2020 · Giulia Meoni, Elisa Giommoni, et al. · Anti-Cancer Drugs · 12
PDF
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
2021 · Carmelo Tibaldi, Francesca Mazzoni, et al. · Anti-Cancer Agents in Medicinal Chemistry · 10
Single‐stage operation using hypothermic circulatory arrest to remove uterine intravenous leiomyomatosis extended to the vena cava and right atrium
2014 · Benedetta Pesi, Luca Moraldi, et al. · International Journal of Gynecology & Obstetrics · 6
Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
2025 · Maria Lucia Reale, Daniela Scattolin, et al. · Lung Cancer · 5
PDF
Massive intrathoracic lipoma in men1 syndrome
2014 · Alessandro Sturiale, Francesco Giudici, et al. · International Journal of Surgery Case Reports · 5
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification
2014 · Giulia Meoni, Lorenzo Antonuzzo, et al. · Endocrine Journal · 5
PDF
Are Circulating Tumor Cells a New, Valid Prognostic Marker in Neuroendocrine Tumors?
2013 · Lorenzo Antonuzzo, Giulia Meoni, et al. · Journal of Clinical Oncology · 5
PDF
Pseudoprogression in lung cancer: a case report
2020 · Giulia Meoni, Nicola Libertà Decarli, et al. · Exploration of Targeted Anti-tumor Therapy · 4
Prolonged response to trabectedin in a heavily pretreated patient with metastatic endometrial carcinoma: A case report and literature review
2011 · Giulia Meoni, Fabiana Letizia Cecere, et al. · Gynecologic Oncology Case Reports · 3
PDF
Braf-mutant metastatic non–small-cell lung cancer: Real world data from the Italian biomarker atlas database
2025 · Claudio Sini, Alessandro Russo, et al. · European Journal of Cancer · 2
Outcome of Crizotinib Treatment in a Young Woman with Heavily Pretreated ROS1-positive Lung Cancer
2015 · Paolo Petreni, Francesca Mazzoni, et al. · Tumori Journal · 2
EGFR-mutant NSCLC progressing on first-line osimertinib: rebiopsy in real-world and impact of second-line therapies (the “Rebiopsy on Osi” study)
2026 · Eleonora Gariazzo, Francesca Colamartini, et al. · The Oncologist · 1
PDF
Amivantamab in advanced non–small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real‐world data from the Italian ATLAS Registry
2026 · Francesco Passiglia, Antonio Passaro, et al. · Cancer · 1
PDF
P3.12.15 Activity and Tolerability of MET Tkis in METex14 NSCLC: Updated Real-World Data From the Italian Biomarker Atlas Database
2025 · M.L. Reale, A. Mogavero, et al. · Journal of Thoracic Oncology
P2.16A.01 Actionable Alterations Identification in NSCLC by Comprehensive Genomic Profiling for Clinical Trial Enrollment: EPROPA
2024 · S. Vallone, F. Passiglia, et al. · Journal of Thoracic Oncology
Update of NGS analysis of Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor).
2020 · Silvia Gasperoni, Francesca Castiglione, et al. · Journal of Clinical Oncology
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor).
2019 · Silvia Gasperoni, Luca Messerini, et al. · Journal of Clinical Oncology
A Randomized Phase III Multicenter Trial of Customized Chemotherapy Versus Standard of Care for 1St Line Treatment of Elderly Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc): the Elderly Patient Individualized Chemotherapy (Epic) Trial
2014 · T. Vavala, S. Novello, et al. · Annals of Oncology
PDF
New Knowledge in the Diagnosis and Medical Treatment of Pancreatic Neuroendocrine Tumors
2013 · Lorenzo Antonuzzo, Luca Messerini, et al. · Springer eBooks
Customized First Line Chemotherapy According to ERCC1 and RRM1 SNPS in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients: A Phase II Study
2012 · F. Mazzoni, G. Meoni, et al. · Annals of Oncology
PDF
Customized first-line chemotherapy according to ERCC1 and RRM1 SNPs in advanced NSCLC patients: A phase II study.
2012 · Francesca Mazzoni, Fabiana Letizia Cecere, et al. · Journal of Clinical Oncology
Works count: 25
Citation count: 190
H-index: 6
I10-index: 6
Year
Topic
Type